These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2796512)

  • 1. [A fatal drug-induced autoimmune syndrome].
    Weitoft T; Domeij-Nyberg B
    Lakartidningen; 1989 Sep; 86(39):3260-1. PubMed ID: 2796512
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of cardiolipin antibodies should be done before penicillamine treatment].
    Kjernsmo A
    Lakartidningen; 1989 Nov; 86(48):4208. PubMed ID: 2593752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Autoimmune thyroiditis. A rare complication of treatment with D-penicillamine (author's transl)].
    Bertrand JL; Rousset H; Queneau P; Ollagnier M
    Therapie; 1981; 36(3):333-6. PubMed ID: 7292412
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune insulin syndrome in a patient with progressive systemic sclerosis receiving penicillamine.
    Herranz L; Rovira A; Grande C; Suarez A; Martinez-Ara J; Pallardo LF; Gómez-Pan A
    Horm Res; 1992; 37(1-2):78-80. PubMed ID: 1398479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced autoimmune disease.
    Spears CJ; Batchelor JR
    Adv Nephrol Necker Hosp; 1987; 16():219-29. PubMed ID: 3101425
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].
    Delrieu F; Menkes CJ; Sainte-Croix A; Delbarre F; Babinet P; Chesneau AM
    Nouv Presse Med; 1975 Nov; 4(40):2890(1). PubMed ID: 1215207
    [No Abstract]   [Full Text] [Related]  

  • 7. Granulocyte autoantibodies--markers for drug-induced autoimmune adverse effects.
    Nässberger L
    Clin Nephrol; 1993 May; 39(5):288. PubMed ID: 8513609
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal change nephropathy and pemphigus vulgaris associated with penicillamine treatment of rheumatoid arthritis.
    Savill JS; Chia Y; Pusey CD
    Clin Nephrol; 1988 May; 29(5):267-70. PubMed ID: 3396226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penicillamine--friend or enemy?].
    Yodfat O; Shoenfeld Y
    Harefuah; 1994 Mar; 126(6):328-34. PubMed ID: 8194790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Penicillamine-induced polymyositis (author's transl)].
    Bettendorf U; Neuhaus R
    Dtsch Med Wochenschr; 1974 Dec; 99(49):2513, 2522-5. PubMed ID: 4548017
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of T helper 17 cells in D-penicillamine-induced autoimmune disease in Brown Norway rats.
    Zhu X; Li J; Liu F; Uetrecht JP
    Toxicol Sci; 2011 Apr; 120(2):331-8. PubMed ID: 21227906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of D-penicillamine treatment of rheumatoid poly-arthritis].
    Camus JP; Crouzet J; Prier A; Leca AP
    Therapie; 1976; 31(3):385-97. PubMed ID: 136767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected adverse reactions of D-penicillamine.
    Stein HB; Chalmers A; Schroeder ML; Dillon A
    Clin Invest Med; 1984; 7(1):73-6. PubMed ID: 6723128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [D-penicillamine: mechanism of cellular action and induced autoimmune diseases].
    Meyer O
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):15-20. PubMed ID: 2939541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.
    Derk CT; Jimenez SA
    J Rheumatol; 2003 Jul; 30(7):1616-20. PubMed ID: 12858467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myasthenic syndrome during treatment with D penicillamine. A recent case].
    Verret JM; Lignac N; Kahn MF
    Ann Med Interne (Paris); 1977; 128(6-7):557-60. PubMed ID: 921113
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunobiology of D-penicillamine.
    Dawkins RL; Zilko PJ; Carrano J; Garlepp MJ; McDonald BL
    J Rheumatol Suppl; 1981; 7():56-61. PubMed ID: 6971938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.